Slimming Down: Glaxo Fat Pill Has Thin Sales

Introduced to much fanfare a year ago, the Alli diet pill isn’t fattening Glaxo’s bottom line. The over-the-counter weight-loss pill has been tried by about 4 million people since then, but that is less than some Wall Streeters were expecting. Given the craving among Americans to lose weight, the preliminary figures are “pretty pretty underwhelming,” Steve Brozak, an analyst with WBB Securities, tells the Associated Press. The problem, he says, may be that the marketing campaign stresses the